Eyecare

 

Anti-VEGF Therapy for Diabetic Retinopathy Gets to the Root Cause

September 14, 2020

Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.

ADA's Dr. Robert Gabbay Discusses Patient, System Challenges to Eyecare

September 13, 2020

Less than half of Americans with diabetes get annual eye exams, says Robert Gabbay, M.D.,Ph.D., FACP, in this third of a four-part video series. Gabbay became chief scientific and medical officer for the American Diabetes Association this summer.

Diabetes Drugs and Retinopathy: So Far, It's All About Lowering A1C Level

September 12, 2020

In this second of a four-part video series, ADA Chief Science and Medical Officer Robert Gabbay, MD, PhD, FACP, says data showing kidney benefits of SGLT2 inhibitors may indicate protection against retinopathy but research is needed.

Diabetes Can Lead to Leaky Retinal Blood Vessels, Sudden Blindness

September 11, 2020

The American Diabetes Association and other groups are mounting a public health campaign to encourage people with diabetes to get annual eye exams. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, FACP, explains "leaky blood vessels" and diabetic retinopathy in this first of a four-part video series.